Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

These 5 Drugmakers' Earnings Excelled This Quarter
Investors.com
Wednesday, November 5, 2014 - 7:37am
tags:
earnings, Alexion, Biogen Idec, Jazz Pharmaceuticals, Celgene, Allergan, Actavis
Diabetes Analyst: Sanofi CEO's Firing May Spell Trouble for MannKind Afrezza Partnership
TheStreet.com
Tuesday, November 4, 2014 - 2:23pm
tags:
diabetes, Sanofi, Chris Viehbacher
Teva expands laquinimod clinical development
Seeking Alpha
Tuesday, November 4, 2014 - 2:21pm
tags:
Teva Pharmaceutical, laquinimod, MS, multiple sclerosis
Forest recalls another 90,000-plus bottles of Bystolic
Fierce Pharma Manufacturing
Tuesday, November 4, 2014 - 1:59pm
tags:
Forest Labs, product recalls, Bystolic
Ackman Win Over Allergan on Vote May Clear Way Buyout
Bloomberg
Tuesday, November 4, 2014 - 1:45pm
tags:
Bill Ackman, Allergan, Valeant Pharmaceuticals, M&A
Some Payments to Docs Don’t Have to be Reported to Sunshine Database
WSJ Pharmalot
Tuesday, November 4, 2014 - 1:31pm
tags:
physician payments, Physician Payment Sunshine Act
2015 Packed With Catalysts For Neurocrine Bio
Yahoo/Zacks.com
Tuesday, November 4, 2014 - 1:25pm
tags:
Neurocrine Biosciences
Novo Nordisk builds blockbuster case with promising PhIII obesity data
Fierce Biotech
Tuesday, November 4, 2014 - 10:39am
tags:
Novo Nordisk, obesity, liraglutide
AstraZeneca Is Attractive Even Without Pfizer Bid
Seeking Alpha
Tuesday, November 4, 2014 - 10:35am
tags:
AstraZeneca, M&A, Pfizer
Amgen ovarian cancer drug fails to improve overall survival
Reuters
Tuesday, November 4, 2014 - 10:30am
tags:
Amgen, ovarian cancer, trebananib
FDA Review of Rockwell's Dialysis Therapy Raises Doubts About Need
TheStreet.com
Tuesday, November 4, 2014 - 10:26am
tags:
Rockwell Medical, devices, dialysis, Triferic, FDA
Impax Labs misses 3Q profit forecasts
Yahoo/AP
Tuesday, November 4, 2014 - 9:54am
tags:
earnings, Impax Labs
Small Device Maker Fights FDA on ‘Grandfather’ Claim
Medical Device and Diagnostics Industry
Tuesday, November 4, 2014 - 9:33am
tags:
devices, FDA, Pharmaceutical Innovations
FDA Clears ISCO's Stem Cell Line for Clinical Uses
Yahoo
Tuesday, November 4, 2014 - 9:26am
tags:
stem cells, FDA, ISCO
Meet The Biopharma Stock That Lost 34% Last Week
Yahoo/Benzinga
Tuesday, November 4, 2014 - 9:13am
tags:
Aegerion Pharmaceuticals
Tekmira Shares Surge Amid Promise of Ebola Treatment
Bloomberg
Tuesday, November 4, 2014 - 9:12am
tags:
Tekmira, ebola virus, TKM-EBOLA
AstraZeneca strengthens cancer business with new deals
Yahoo/Reuters
Tuesday, November 4, 2014 - 9:11am
tags:
AstraZeneca, cancer, Definiens, M&A
Stryker to pay at least $1.43 billion to settle thousands of lawsuits over hip implants
Yahoo/AP
Tuesday, November 4, 2014 - 9:06am
tags:
Stryker, hip implants, devices
Orexigen's Contrave Has Modest Start
Seeking Alpha
Monday, November 3, 2014 - 6:42pm
tags:
Orexigen, Contrave, obesity
Allergan Confirms White Knight Approach By Actavis, But Coyly
WSJ Online
Monday, November 3, 2014 - 3:46pm
tags:
Allergan, M&A, Valeant Pharmaceuticals, Actavis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.